Alto Neuroscience Wants to Revolutionize Mental Health Treatment
  • 3 months ago
Fresh of its IPO at the NYSE, CEO of Alto Neuroscience Dr. Amit Etkin discusses how the company wants to innovate psychiatric medicine.